Exact Mass: 450.2056
Exact Mass Matches: 450.2056
Found 392 metabolites which its exact mass value is equals to given mass value 450.2056
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sofalcone
Sofalcone belongs to the family of Chalcones and Dihydrochalcones. These are organic compounds containing 1,3-Diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar,or its derivatives formed by substitution. D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
Androsta-1,4-diene-17-carboxylicacid, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-, fluoromethyl ester, (11b,17a)-
2'-Carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy) chalcone
Cediranib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
Ppack
Phenylalanyl-prolyl-arginine-chloromethyl ketone
Rivenprost
11-Hydroxy-19-(3,4-dihydroxybenzoyloxy)-abieta-5,7,9(11),13-tetraene-12-one
19-O-(3,4-dihydroxybenzoyl)-11,12-dihydroxy-20(10->5)-abeo-abieta-1(10),6,8,11,13-tetraene|plectranthol A
15,16-epoxy-8alpha-(benzoyloxy)methyl-2-oxocleroda-3,13(16),14-trien-18-oic acid|rel-6-[(benzoyloxy)methyl]-5-[2-(3-furyl)ethyl]-5,8a-dimethyl-3-oxo-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid
(2S)-6-(gamma,gamma-dimethylallyl)-5-hydroxy-3,4-dimethoxy-6,6-dimethylpyran<2,3:7,8>flavanone
Val Ala Phe Asp
O(C)c1c(OC)ccc(C=2C(=O)c3c(O)c(C/C=C(\C)/C)c(O)c(C/C=C(\C)/C)c3OC=2)c1
Ala Asp Phe Val
Ala Asp Val Phe
Ala Phe Asp Val
Ala Phe Val Asp
Ala His His Ser
Ala His Ser His
Ala Met Met Val
Ala Met Val Met
Ala Pro Thr Tyr
Ala Pro Tyr Thr
Ala Ser His His
Ala Thr Pro Tyr
Ala Thr Tyr Pro
Ala Val Asp Phe
Ala Val Phe Asp
Ala Val Met Met
Ala Tyr Pro Thr
Ala Tyr Thr Pro
Cys Cys Ile Ile
Cys Cys Ile Leu
Cys Cys Leu Ile
Cys Cys Leu Leu
Cys Ile Cys Ile
Cys Ile Cys Leu
Cys Ile Ile Cys
Cys Ile Leu Cys
Cys Leu Cys Ile
Cys Leu Cys Leu
Cys Leu Ile Cys
Cys Leu Leu Cys
Cys Met Val Val
Cys Val Met Val
Cys Val Val Met
Asp Ala Phe Val
Asp Ala Val Phe
Asp Phe Ala Val
Asp Phe Gly Ile
Asp Phe Gly Leu
Asp Phe Ile Gly
Asp Phe Leu Gly
Asp Phe Val Ala
Asp Gly Phe Ile
Asp Gly Phe Leu
Asp Gly Ile Phe
Asp Gly Leu Phe
Asp Ile Phe Gly
Asp Ile Gly Phe
Asp Leu Phe Gly
Asp Leu Gly Phe
Asp Val Ala Phe
Asp Val Phe Ala
Glu Phe Gly Val
Glu Phe Val Gly
Glu Gly Phe Val
Glu Gly Val Phe
Glu Thr Thr Thr
Glu Val Phe Gly
Glu Val Gly Phe
Phe Ala Asp Val
Phe Ala Val Asp
Phe Asp Ala Val
Phe Asp Gly Ile
Phe Asp Gly Leu
Phe Asp Ile Gly
Phe Asp Leu Gly
Phe Asp Val Ala
Phe Glu Gly Val
Phe Glu Val Gly
Phe Gly Asp Ile
Phe Gly Asp Leu
Phe Gly Glu Val
Phe Gly Ile Asp
Phe Gly Leu Asp
Phe Gly Val Glu
Phe Ile Asp Gly
Phe Ile Gly Asp
Phe Leu Asp Gly
Phe Leu Gly Asp
Phe Pro Ser Thr
Phe Pro Thr Ser
Phe Ser Pro Thr
Phe Ser Thr Pro
Phe Thr Pro Ser
Phe Thr Ser Pro
Phe Val Ala Asp
Phe Val Asp Ala
Phe Val Glu Gly
Phe Val Gly Glu
Gly Asp Phe Ile
Gly Asp Phe Leu
Gly Asp Ile Phe
Gly Asp Leu Phe
Gly Glu Phe Val
Gly Glu Val Phe
Gly Phe Asp Ile
Gly Phe Asp Leu
Gly Phe Glu Val
Gly Phe Ile Asp
Gly Phe Leu Asp
Gly Phe Val Glu
Gly His His Thr
Gly His Thr His
Gly Ile Asp Phe
Gly Ile Phe Asp
Gly Ile Met Met
Gly Leu Asp Phe
Gly Leu Phe Asp
Gly Leu Met Met
Gly Met Ile Met
Gly Met Leu Met
Gly Met Met Ile
Gly Met Met Leu
Gly Thr His His
Gly Val Glu Phe
Gly Val Phe Glu
His Ala His Ser
His Ala Ser His
His Gly His Thr
His Gly Thr His
His His Ala Ser
His His Gly Thr
His His Ser Ala
His His Thr Gly
His Ser Ala His
His Ser His Ala
His Thr Gly His
His Thr His Gly
Ile Cys Cys Ile
Ile Cys Cys Leu
Ile Cys Ile Cys
Ile Cys Leu Cys
Ile Asp Phe Gly
Ile Asp Gly Phe
Ile Phe Asp Gly
Ile Phe Gly Asp
Ile Gly Asp Phe
Ile Gly Phe Asp
Ile Gly Met Met
Ile Ile Cys Cys
Ile Leu Cys Cys
Ile Met Gly Met
Ile Met Met Gly
Ile Met Ser Thr
Ile Met Thr Ser
Ile Ser Met Thr
Ile Ser Thr Met
Ile Thr Met Ser
Ile Thr Ser Met
Leu Cys Cys Ile
Leu Cys Cys Leu
Leu Cys Ile Cys
Leu Cys Leu Cys
Leu Asp Phe Gly
Leu Asp Gly Phe
Leu Phe Asp Gly
Leu Phe Gly Asp
Leu Gly Asp Phe
Leu Gly Phe Asp
Leu Gly Met Met
Leu Ile Cys Cys
Leu Leu Cys Cys
Leu Met Gly Met
Leu Met Met Gly
Leu Met Ser Thr
Leu Met Thr Ser
Leu Ser Met Thr
Leu Ser Thr Met
Leu Thr Met Ser
Leu Thr Ser Met
Met Ala Met Val
Met Ala Val Met
Met Cys Val Val
Met Gly Ile Met
Met Gly Leu Met
Met Gly Met Ile
Met Gly Met Leu
Met Ile Gly Met
Met Ile Met Gly
Met Ile Ser Thr
Met Ile Thr Ser
Met Leu Gly Met
Met Leu Met Gly
Met Leu Ser Thr
Met Leu Thr Ser
Met Met Ala Val
Met Met Gly Ile
Met Met Gly Leu
Met Met Ile Gly
Met Met Leu Gly
Met Met Val Ala
Met Ser Ile Thr
Met Ser Leu Thr
Met Ser Thr Ile
Met Ser Thr Leu
Met Thr Ile Ser
Met Thr Leu Ser
Met Thr Ser Ile
Met Thr Ser Leu
Met Thr Thr Val
Met Thr Val Thr
Met Val Ala Met
Met Val Cys Val
Met Val Met Ala
Met Val Thr Thr
Met Val Val Cys
Pro Ala Thr Tyr
Pro Ala Tyr Thr
Pro Phe Ser Thr
Pro Phe Thr Ser
Pro Ser Phe Thr
Pro Ser Thr Phe
Pro Thr Ala Tyr
Pro Thr Phe Ser
Pro Thr Ser Phe
Pro Thr Tyr Ala
Pro Tyr Ala Thr
Pro Tyr Thr Ala
Ser Ala His His
Ser Phe Pro Thr
Ser Phe Thr Pro
Ser His Ala His
Ser His His Ala
Ser Ile Met Thr
Ser Ile Thr Met
Ser Leu Met Thr
Ser Leu Thr Met
Ser Met Ile Thr
Ser Met Leu Thr
Ser Met Thr Ile
Ser Met Thr Leu
Ser Pro Phe Thr
Ser Pro Thr Phe
Ser Thr Phe Pro
Ser Thr Ile Met
Ser Thr Leu Met
Ser Thr Met Ile
Ser Thr Met Leu
Ser Thr Pro Phe
Thr Ala Pro Tyr
Thr Ala Tyr Pro
Thr Glu Thr Thr
Thr Phe Pro Ser
Thr Phe Ser Pro
Thr Gly His His
Thr His Gly His
Thr His His Gly
Thr Ile Met Ser
Thr Ile Ser Met
Thr Leu Met Ser
Thr Leu Ser Met
Thr Met Ile Ser
Thr Met Leu Ser
Thr Met Ser Ile
Thr Met Ser Leu
Thr Met Thr Val
Thr Met Val Thr
Thr Pro Ala Tyr
Thr Pro Phe Ser
Thr Pro Ser Phe
Thr Pro Tyr Ala
Thr Ser Phe Pro
Thr Ser Ile Met
Thr Ser Leu Met
Thr Ser Met Ile
Thr Ser Met Leu
Thr Ser Pro Phe
Thr Thr Glu Thr
Thr Thr Met Val
Thr Thr Thr Glu
Thr Thr Val Met
Thr Val Met Thr
Thr Val Thr Met
Thr Tyr Ala Pro
Thr Tyr Pro Ala
Val Ala Asp Phe
Val Ala Met Met
Val Cys Met Val
Val Cys Val Met
Val Asp Ala Phe
Val Asp Phe Ala
Val Glu Phe Gly
Val Glu Gly Phe
Val Phe Ala Asp
Val Phe Asp Ala
Val Phe Glu Gly
Val Phe Gly Glu
Val Gly Glu Phe
Val Gly Phe Glu
Val Met Ala Met
Val Met Cys Val
Val Met Met Ala
Val Met Thr Thr
Val Met Val Cys
Val Thr Met Thr
Val Thr Thr Met
Val Val Cys Met
Val Val Met Cys
Tyr Ala Pro Thr
Tyr Ala Thr Pro
Tyr Pro Ala Thr
Tyr Pro Thr Ala
Tyr Thr Ala Pro
Tyr Thr Pro Ala
6β-Hydroxytriamcinolone acetonide
Sofalcone
A member of the class of chalcones that is benzene in which the hydrogens at positions 1,2 and 5 are replaced by carboxymethoxy, (1E)-1-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-oxoprop-1-en-3-yl, and (3-methylbut-2-en-1-yl)oxy groups, respectively. It is a gastrointestinal drug currently used for treatment of gastritis and gastric ulcers in Japan and South Korea. D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
4-[3-(3,4-dihydroisoquinolin-1-yl)phenyl]-N,N-diphenylaniline
H-D-Pro-Phe-Arg-chloromethylketone trifluoroacetate salt
D-Pro-Phe-Arg-Chloromethylketone, a inhibitor of coagulation factor XII and plasma kallikrein, plays an important role in thrombosis and inflammation[1].
Leniolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Methyl 1-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)piperidine-4-carboxylate
Cediranib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
Phenylalanyl-prolyl-arginine-chloromethyl ketone
(Z,2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-phosphonopent-3-enoic acid
methyl 4-[2-[3-hydroxy-2-[(E)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl]-5-oxocyclopentyl]ethylsulfanyl]butanoate
(2S)-6-(gamma,gamma-dimethylallyl)-5-hydroxy-3,4-dimethoxy-6,6-dimethylpyran[2,3:7,8]flavanone
An extended flavonoid that consists of (2S)-flavanone substituted by a hydroxy group at position 5, methoxy groups at positions 3 and 4 , a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor.
6-[(4-Methyl-1-piperidinyl)sulfonyl]-2-(4-phenyl-1-piperazinyl)quinoline
5-[4-(Diphenylmethyl)-1-piperazinyl]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile
15,16-Epoxy-8alpha-(benzoyloxy)methyl-2-oxocleroda-3,13(16),14-trien-18-oic acid, (rel)-
A natural product found in Dodonaea polyandra.
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
(2S)-N-[(3R,3R,4S,5R)-4-[fluoro(dimethyl)silyl]-5-(2-hydroxyethyl)-3-methyl-2-oxo-1-prop-2-enyl-5-spiro[indole-3,2-oxolane]yl]-2-hydroxypropanamide
Asimadoline (hydrochloride)
Asimadoline (EMD-61753) hydrochloride is an orally active, selective and peripherally active κ-opioid agonist with IC50s of 5.6 nM (guinea pig) and 1.2 nM (human recombinant). Asimadoline hydrochloride has low permeability across the blood brain barrier and has peripheral anti-inflammatory actions. Asimadoline hydrochloride ameliorates allodynia in diabetic rats and has the potential for irritable bowel syndrome (IBS)[1][2][3].
NNC 05-2090 (hydrochloride)
NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50< /sub>: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases[1][2][3].
OS-3-106
OS-3-106 is a potent, BBB-penetrated and selective dopamine D3 receptor (D3R) agonist. OS-3-106 binds with high affinity (Ki = 0.2 nM) at the D3R. OS-3-106 can be used for psychoactivator addiction research[1].